Cat.#: ACPP-1344
| Despition | Olig2 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1705 | Human NXPH1 Protein (AC1705) | 5 µg | inquiry |
| ACPP-1013 | Recombinant Human GPCR GPRC5B Protein (Fc Tag) (AC1013) | 50 µg | inquiry |
| ACPP-1130 | Native Bovine GFAP Protein (AC1130) | 25 µl | inquiry |
| ACPP-1287 | Dopamine Receptor D1 Blocking Peptide (AC1287) | 250 µg | inquiry |
| ACPP-1043 | Recombinant Human MERTK Protein (Fc Tag) (AC1043) | 50 µg | inquiry |
| ACPP-1051 | Recombinant Human Amyloid Precursor Protein Protein (6×His Tag) (AC1051) | 50 µg | inquiry |
| ACPP-1073 | Dopamine D5 Receptor Blocking Peptide (AC1073) | 250 µg | inquiry |
| ACPP-1738 | Human PNOC Protein (AC1738) | 5 µg | inquiry |
| ACPP-1212 | PAX8 Blocking Peptide (AC1212) | 250 µg | inquiry |
| ACPP-1041 | Recombinant Human Wnt3a Protein (AC1041) | 50 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.